Posts in the “Squamous Cell Squamous Cell” category:

Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer

Posted by Samantha Powell on June 23rd, 2014 |

This month, the National Cancer Institute (NCI), along with the FDA, the Southwest Oncology Group (SWOG), several private foundations and five pharmaceutical companies, launched a prospective, biomarker-driven study of new drugs for squamous cell lung cancer. The Lung-MAP trial is remarkable for its collaborative nature, and scope. The study will identify “actionable” molecular abnormalities in… Read More

Two Oncogenes Work Together to Sustain Population of Cells in Lung Squamous Cell Carcinoma

Posted by Samantha Powell on February 10th, 2014 |

Date: 2/10/14 Outlet Full Name: News Medical Author: No author Patients with a common form of lung cancer — lung squamous cell carcinoma — have very few treatment options. That situation may soon change. A team of cancer biologists at Mayo Clinic in Florida is reporting in the Feb. 10 issue of Cancer Cell… Read More

RNA diagnostic test from paraffin improves lung cancer diagnosis over routine microscopic evaluation alone

Posted by Samantha Powell on July 16th, 2013 |

Date: 7/17/13 Outlet Full Name: UNC Health Care and UNC School of Medicine Scientists at the Universities of North Carolina and Utah have developed a histology expression predictor for the most common types of lung cancer: adenocarcinoma, carcinoid, small cell carcinoma and squamous cell carcinoma. Knowing what type of lung cancer a patient has is… Read More